These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 16528677)

  • 1. Inflammation and infection in Parkinson's disease.
    Arai H; Furuya T; Mizuno Y; Mochizuki H
    Histol Histopathol; 2006 Jun; 21(6):673-8. PubMed ID: 16528677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory process as a determinant factor for the degeneration of substantia nigra dopaminergic neurons.
    Herrera AJ; Tomás-Camardiel M; Venero JL; Cano J; Machado A
    J Neural Transm (Vienna); 2005 Jan; 112(1):111-9. PubMed ID: 15599609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of nigral cell death in Parkinson's disease.
    Przedborski S
    Parkinsonism Relat Disord; 2005 Jun; 11 Suppl 1():S3-7. PubMed ID: 15885625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ulcerative colitis exacerbates lipopolysaccharide-induced damage to the nigral dopaminergic system: potential risk factor in Parkinson`s disease.
    Villarán RF; Espinosa-Oliva AM; Sarmiento M; De Pablos RM; Argüelles S; Delgado-Cortés MJ; Sobrino V; Van Rooijen N; Venero JL; Herrera AJ; Cano J; Machado A
    J Neurochem; 2010 Sep; 114(6):1687-700. PubMed ID: 20584104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease.
    Anglade P; Vyas S; Javoy-Agid F; Herrero MT; Michel PP; Marquez J; Mouatt-Prigent A; Ruberg M; Hirsch EC; Agid Y
    Histol Histopathol; 1997 Jan; 12(1):25-31. PubMed ID: 9046040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FADD: A link between TNF family receptors and caspases in Parkinson's disease.
    Hartmann A; Mouatt-Prigent A; Faucheux BA; Agid Y; Hirsch EC
    Neurology; 2002 Jan; 58(2):308-10. PubMed ID: 11805265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms of selective dopaminergic neuronal death in Parkinson's disease.
    Barzilai A; Melamed E
    Trends Mol Med; 2003 Mar; 9(3):126-32. PubMed ID: 12657434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age and Parkinson's disease-related neuronal death in the substantia nigra pars compacta.
    Eriksen N; Stark AK; Pakkenberg B
    J Neural Transm Suppl; 2009; (73):203-13. PubMed ID: 20411779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammation as a causative factor in the aetiology of Parkinson's disease.
    Whitton PS
    Br J Pharmacol; 2007 Apr; 150(8):963-76. PubMed ID: 17339843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuronal vulnerability in Parkinson's disease.
    Hirsch EC; Faucheux B; Damier P; Mouatt-Prigent A; Agid Y
    J Neural Transm Suppl; 1997; 50():79-88. PubMed ID: 9120427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Research progress on neural mechanism of peripheral inflammation in Parkinson's disease].
    Liu YT; Sun MH; Cai CW; Ren C; Niu HC
    Sheng Li Xue Bao; 2019 Oct; 71(5):732-740. PubMed ID: 31646327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroinflammation in Parkinson's disease: a target for neuroprotection?
    Hirsch EC; Hunot S
    Lancet Neurol; 2009 Apr; 8(4):382-97. PubMed ID: 19296921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
    Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
    Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathological mechanisms of Parkinson's disease].
    Matsui H; Takahashi R
    Brain Nerve; 2009 Apr; 61(4):441-6. PubMed ID: 19378814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trichloroethylene and Parkinson's Disease: Risk Assessment.
    Liu M; Shin EJ; Dang DK; Jin CH; Lee PH; Jeong JH; Park SJ; Kim YS; Xing B; Xin T; Bing G; Kim HC
    Mol Neurobiol; 2018 Jul; 55(7):6201-6214. PubMed ID: 29270919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation in Parkinson's Disease: Mechanisms and Therapeutic Implications.
    Pajares M; I Rojo A; Manda G; Boscá L; Cuadrado A
    Cells; 2020 Jul; 9(7):. PubMed ID: 32674367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron accumulation in Parkinson's disease.
    Mochizuki H; Yasuda T
    J Neural Transm (Vienna); 2012 Dec; 119(12):1511-4. PubMed ID: 23070727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation in Parkinson's diseases and other neurodegenerative diseases: cause and therapeutic implications.
    Wilms H; Zecca L; Rosenstiel P; Sievers J; Deuschl G; Lucius R
    Curr Pharm Des; 2007; 13(18):1925-8. PubMed ID: 17584117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocorticoid receptor is involved in the neuroprotective effect of ginsenoside Rg1 against inflammation-induced dopaminergic neuronal degeneration in substantia nigra.
    Sun XC; Ren XF; Chen L; Gao XQ; Xie JX; Chen WF
    J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt A):94-103. PubMed ID: 26455404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Converging roles of ion channels, calcium, metabolic stress, and activity pattern of Substantia nigra dopaminergic neurons in health and Parkinson's disease.
    Duda J; Pötschke C; Liss B
    J Neurochem; 2016 Oct; 139 Suppl 1(Suppl Suppl 1):156-178. PubMed ID: 26865375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.